Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines

Because of its role as an immune checkpoint, levels of soluble programmed cell death protein-1 (sPD-1) could be useful as a prognostic biomarker or predictive biomarker in cancer patients treated with vaccines. Very low levels of sPD-1 may indicate lack of an existing anti-cancer immune response; ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillman, Robert O., Nistor, Gabriel I., McLelland, Bryce T., Hsieh, Candace, Poole, Aleksandra J., Cornforth, Andrew N., Keirstead, Hans S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731107/
https://www.ncbi.nlm.nih.gov/pubmed/31523394
http://dx.doi.org/10.18632/oncotarget.27164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731107/
https://www.ncbi.nlm.nih.gov/pubmed/31523394
http://dx.doi.org/10.18632/oncotarget.27164

Ejemplares similares